Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
224 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (3)
  • (-) Closed (3)

Medical Condition

  • Show all (997)
  • Addiction (12)
    • Alcohol (1)
    • Cocaine (2)
    • (-) Marijuana (2)
    • Nicotine (2)
    • Opioids (4)
  • Allergy, Asthma, & Immunology (12)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (25)
  • Blood Disorders (18)
  • Bone & Muscle (8)
  • Cancer (93)
  • Child Development (4)
  • COVID-19 (Coronavirus) (28)
  • Critical Illness (1)
  • Diabetes (14)
  • Ear, Nose and Throat (5)
  • Endocrine & Metabolic Disease (10)
  • Eye (7)
  • Gastrointestinal and Digestive Diseases (23)
  • Hair and Skin Disorders (2)
  • Headaches (5)
  • Healthy Volunteers (143)
  • Heart Disease (109)
  • Infectious Disease (38)
  • Insomnia (2)
  • Kidney Disease (12)
  • Liver Disease (40)
  • Lung Disease (29)
  • (-) Meniere's Disease (1)
  • Neurological Disorders (95)
  • Nutrition (3)
  • Obesity (1)
  • Obstetrics & Gynecology (46)
  • Pain Management (1)
  • Pediatrics (84)
  • Psychiatric Disorders (61)
  • Rehabilitation (7)
  • Stroke (5)
  • Surgery (7)
  • Transplant (33)
  • Urology (3)
  • Vascular Conditions (9)
Displaying 1 - 3 of 3

Study of Brain Activity and Decision-Making in Marijuana Smokers

Condition: Addiction / Marijuana
Investigator: Suzette Evans, PhD
Status: Closed
RESEARCH VOLUNTEERS: Healthy male and female (age 21-60) MARIJUANA SMOKERS needed to study effects of marijuana on brain activity and decision-making. The study involves 2-3 outpatient visits and a 5-day/5-night stay at the NYS Psychiatric Institute and includes Magnetic Resonance Imaging (MRI) scans. Compensation for time could be between $870-$1230 (…
Read More

Medication treatment of marijuana use and Attention-Deficit/Hyperactivity disorder

Condition: Addiction / Marijuana
Investigator: Frances Levin, MD
Status: Closed
The study is an outpatient treatment study of the safety and benefit of extended-release mixed amphetamine salt (Adderall-XR) in the treatment of individuals with cannabis use disorder and Attention Deficit/Hyperactivity Disorder (ADHD). The study is a 13-week trial and requires participants to come twice per week. The primary objective of the study is to…
Read More

A study for subjects with Unilateral Menieres disease using corticosteroid (OTO-104)

Condition: Meniere's Disease
Investigator: Anil Lalwani, MD
Status: Closed
Meniere's Disease is an inner ear disorder that causes episodes of vertigo. The purpose of this study is to test the effectiveness and safety of OTO-104 compared to placebo in subjects with Menieres disease. OTO-104 contains an active ingredient, called dexamethasone, which is a commonly used corticosteroid that has been prescribed by doctors for…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science